Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children (Q30228322)

11 June 2017

title

Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children (English)

1 reference

11 June 2017

1 reference

Maria Zambon

1 reference

11 June 2017

Angie Lackenby

1 reference

11 June 2017

Iain Stephenson

1 reference

11 June 2017

Jane Democratis

1 reference

11 June 2017

Teresa McNally

1 reference

11 June 2017

James Smith

1 reference

11 June 2017

Manish Pareek

1 reference

11 June 2017

Joanna Ellis

1 reference

11 June 2017

Alison Bermingham

1 reference

11 June 2017

Karl Nicholson

1 reference

11 June 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

Clinical Infectious Diseases

11 June 2017

1 reference

inferred from page(s)

published in

1 reference

11 June 2017

1 reference

11 June 2017

1 reference

11 June 2017

page(s)

389-396

1 reference

Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern

11 June 2017

cites work

1 reference

Strategies for mitigating an influenza pandemic

21 January 2018

1 reference

Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir

21 January 2018

1 reference

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

21 January 2018

1 reference

Oral oseltamivir treatment of influenza in children.

21 January 2018

1 reference

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

21 January 2018

1 reference

Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.

21 January 2018

1 reference

Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir

21 January 2018

1 reference

Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors

21 January 2018

1 reference

Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1-5 years

21 January 2018

1 reference

Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate

21 January 2018

1 reference

Oseltamivir resistance during treatment of influenza A (H5N1) infection

21 January 2018

1 reference

The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.

21 January 2018

1 reference

Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants

21 January 2018

1 reference

Rational design of potent sialidase-based inhibitors of influenza virus replication

21 January 2018

1 reference

Resistance of influenza viruses to neuraminidase inhibitors--a review.

21 January 2018

1 reference

Mutations of neuraminidase implicated in neuraminidase inhibitors resistance

21 January 2018

1 reference

Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets

21 January 2018

1 reference

Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants

21 January 2018

1 reference

Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.

21 January 2018

1 reference

Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use.

21 January 2018

1 reference

Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors.

21 January 2018

1 reference

Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

21 January 2018

1 reference

Antiviral treatment and prevention of seasonal influenza: a comparative review of recommendations in the European Union

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/596311

1 reference

11 June 2017

1 reference